InfuSystem Holdings, Inc (INFU) income statement
INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/303% above fair value
$14.67−0.12 (-0.81%)
Close on Nov 18, 2026Market cap $292.19MP/E 35.8Yield –
InfuSystem Holdings, Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 57.5%
- Operating margin
- 9.3%
- Net margin
- 6.0%
- Return on equity, FY2025
- 11.5%
Financial strength
- Current ratio
- 2.50
- Debt to equity
- 0.35
- Debt to assets
- 20.9%
- Cash to current liabilities
- 6.3%
Valuation
- P/E ratio
- 35.8
- Price to sales
- 2.04
- Price to book
- 4.94
- Dividend yield
- –
See a number that looks wrong?